Tag: Bright Minds Biosciences

New Resource: Psychedelics Drug Development Tracker

Bright Minds Biosciences Inc. Announces Pricing of Public Marketed Offering of Units

Post published:February 23, 2021
Post category:Press Release

Bright Minds Biosciences Inc. Announces Marketed Public Offering

Post published:February 22, 2021
Post category:Press Release

Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth

Post published:February 10, 2021
Post category:Press Release

Bright Minds Biosciences Announces Listing on Canadian Stock Exchange

Post published:February 5, 2021
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Psychedelic Stocks and Companies
News & Interviews
Psychedelic Sector Jobs
Data Bank

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Psychedelic Sector Overview

Explore the Psychedelic Sector Landscape visually using our new tool.

Psychedelics Patent Trackers

We track the latest patents and filings related to psilocybin and MDMA.

Psychedelics Drug Development Tracker

From drug discovery to regulatory approval, we map drug development in psychedelics.

How to Buy Psychedelic Stocks

Looking to invest in psychedelics? This handy guide explains how to buy stocks and shares outside of Canada.